Skip directly to content

VacciNation: a vision for UK immunisation

Pfizer
Pfizer UK

24th September 2020

Could a new approach to prevention create a healthier and more resilient Britain? Today, Pfizer has launched ‘VacciNation’ - a vision for protecting the health, wealth and resilience of the UK by unlocking the personal and societal value of vaccines at every stage of life.

 

VacciNation sets out a series of thought-provoking ideas to address systemic challenges in the use of, and access to, life-changing and life-saving vaccines, while cementing the UK’s position at the forefront of research and innovation.

These ideas are focused on achieving three priorities:

  • Maximising the value that vaccination can deliver to the nation’s health and the UK economy
  • Unleashing the potential of vaccination across society to tackle major health challenges, regardless of age
  • Making vaccination a priority across the NHS

The UK has a long-standing and proud heritage in vaccine development. VacciNation highlights the potential to build on this legacy and secure the UK’s position as a global leader in preventative healthcare well into the future.


Vaccination is essential in protecting the nation’s health and that of the UK economy. To create a healthier, more resilient Britain, we must think differently about prevention, and prioritise the use of vaccines to help us live longer, healthier lives – which in turn protects the precious resources of our NHS and allows us all to add more to our nation's wealth. VacciNation outlines Pfizer’s vision for vaccination. One of our main asks is the establishment of a new leadership forum which could facilitate greater cross-sector collaboration, creating stronger and clearer accountability for the Government’s forthcoming vaccines strategy. We must realise the benefits of the full spectrum of vaccinations we currently have on offer across our lifetime, whilst also investing to ensure timely access to the vaccines of the future. Through collaboration, the life sciences industry and the healthcare system can deliver an ambitious long-term strategy for vaccination that will boost the health and wealth of the nation."

Darius Hughes, Head of Vaccines, Pfizer UK

Many major health economies prioritise investment in medicines and cures to treat ill health over keeping people well. Today in the UK, we spend £97 billion a year on treating diseases and only £8 billion on preventing them.1 VacciNation calls for a rebalance, allowing us to better understand the longer-term and lifelong benefits of vaccination in maintaining population health and reducing health inequalities, as well as realising significant economic value.2

VacciNation also highlights the potential for the NHS to make vaccination a priority. One of the opportunities is to put adult vaccinations on a par with childhood vaccinations, helping us better meet the demands of a growing and ageing population, and protecting some of the most vulnerable from disease.


VacciNation sets out how a population better protected from disease is within our reach. Vaccination has saved more lives and prevented more serious diseases than any advance in recent medical history.3,4 In fact, only clean water rivals vaccines at reducing infectious diseases and deaths.5 Unlocking the full potential of vaccination at all stages of life  is an opportunity too important to miss. In the last year in England, just 1 in 8 65 year olds were immunised against pneumonia.6 And while those over 70 are eligible for vaccination against shingles, by the age of 76, around 1 in 4 are still unvaccinated.7 There is a need to take urgent action to equip individuals with the right information, as well as provide easy, convenient access to improve uptake of all recommended vaccinations across society."

Dr Gillian Ellsbury, Vaccines Medical Director, Pfizer UK & Ireland

With the release of VacciNation today, Pfizer is looking to build strong, collaborative partnerships to support the UK in tackling the challenges faced by the NHS and to deliver a new generation of innovative vaccines to support health throughout life.

VacciNation: a vision for UK immunisation.pdf (6.97 MB)

 

References

  1. DHSC. Prevention is better than cure: Our vision to help you live well for longer. Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploa... [Last accessed September 2020]
  2. Quilici S, Smith R, et al. Role of vaccination in economic growth. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802686/ [Last accessed June 2020]
  3. ABPI. Vaccines. Available at: https://www.abpi.org.uk/new-medicines/vaccines/. [Last accessed: September 2020]
  4. WHO. Vaccine safety and false contraindications to vaccination. Available at: https://www.euro.who.int/__data/assets/pdf_file/0009/351927/WHO-Vaccine-.... [Last accessed: September 2020]
  5. WHO. Vaccination greatly reduces disease, disability, death and inequity worldwide. Available at: https://www.who.int/bulletin/volumes/86/2/07-040089/en/. [Last accessed: September 2020]
  6. Public Health England. Pneumococcal Polysaccharide Vaccine (PPV) coverage report, England, April 2019 to March 2020. Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploa... [Last accessed September 2020]
  7. Public Health England. Shingles (quarter 3) vaccine coverage report (adults eligible from April to December 2019 and vaccinated to end-March 2020) in England. Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploa... [Last accessed September 2020]

 

PP-VAC-GBR-1604 / Sept 2020